AWM Investment Company Inc. Grows Stock Position in MDxHealth SA (NASDAQ:MDXH)

AWM Investment Company Inc. lifted its holdings in MDxHealth SA (NASDAQ:MDXH - Free Report) by 11.1% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,721,290 shares of the company's stock after purchasing an additional 471,290 shares during the quarter. AWM Investment Company Inc. owned about 9.98% of MDxHealth worth $11,189,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. Renaissance Technologies LLC boosted its position in shares of MDxHealth by 715.2% in the 4th quarter. Renaissance Technologies LLC now owns 123,100 shares of the company's stock worth $292,000 after purchasing an additional 108,000 shares in the last quarter. Perkins Capital Management Inc. boosted its position in shares of MDxHealth by 31.6% in the 4th quarter. Perkins Capital Management Inc. now owns 983,475 shares of the company's stock worth $2,331,000 after purchasing an additional 236,100 shares in the last quarter. Samjo Management LLC raised its stake in MDxHealth by 130.9% in the 4th quarter. Samjo Management LLC now owns 1,824,312 shares of the company's stock worth $4,324,000 after acquiring an additional 1,034,312 shares during the last quarter. Oppenheimer & Co. Inc. raised its stake in MDxHealth by 100.0% in the 4th quarter. Oppenheimer & Co. Inc. now owns 20,000 shares of the company's stock worth $47,000 after acquiring an additional 10,000 shares during the last quarter. Finally, Delta Investment Management LLC purchased a new position in MDxHealth in the 4th quarter worth $81,000.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded MDxHealth to a "hold" rating in a research note on Saturday.

MDxHealth Stock Performance

MDXH stock traded down $0.02 during midday trading on Friday, reaching $2.04. The stock had a trading volume of 60,462 shares, compared to its average volume of 86,415. The stock has a market cap of $96.47 million, a PE ratio of -1.34 and a beta of 1.32. The company has a debt-to-equity ratio of 3.14, a quick ratio of 1.45 and a current ratio of 1.54. The firm has a fifty day simple moving average of $1.67 and a two-hundred day simple moving average of $1.85. MDxHealth SA has a 52-week low of $1.35 and a 52-week high of $3.50.

MDxHealth (NASDAQ:MDXH - Get Free Report) last issued its earnings results on Wednesday, May 14th. The company reported ($0.19) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.13) by ($0.06). The firm had revenue of $24.29 million during the quarter, compared to analysts' expectations of $22.62 million. MDxHealth had a negative return on equity of 1,077.84% and a negative net margin of 49.52%. As a group, equities research analysts anticipate that MDxHealth SA will post -1.15 EPS for the current year.

MDxHealth Company Profile

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its testing solutions includes Select mdx, a non-invasive urine test for prostate cancer that measures the expression of two mRNA cancer-related biomarkers; Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; and Resolved mdx for urinary tract infection that identifies personalized effective antibiotic options against the patient's infection.